Clinical trial

Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

NCT00093782

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-12-01

PhasePHASE2

Study timeline

Study start (unknown)2003-12-01Date precision: month

Registry last updated2017-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Gastrointestinal Carcinoid Tumorunresolved

Pulmonary Carcinoid Tumorunresolved

Recurrent Gastrointestinal Carcinoid Tumorunresolved

Recurrent Islet Cell Carcinomaunresolved

Interventions

temsirolimusDRUG · verified · RxNorm: temsirolimus

laboratory biomarker analysisOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00093782 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.